Enveda Therapeutics, Inc.
H‑1B Sponsor Verified
Yes. Enveda Therapeutics, Inc. filed 14 H-1B labor condition applications (LCAs) with the U.S. Department of Labor from 2022–2026, including 4 so far in 2026. The average H-1B salary is $162,518 and the most sponsored role is Associate Vice President.
Source: U.S. Department of Labor LCA disclosure data. Most recent filing on record: Jun 25, 2026.
LinkedIn ↗Latest Year Filings
4
In 2026
↗ Filter by year
Total H‑1B Filings
14
Since 2020
↗ View records
Avg Annual Salary
$162,518
All years combined
↗ View chart
Top Role
Associate Vice President
↗ Click to filter
Filing trend
H‑1B filings by year for Enveda Therapeutics, Inc.
| Year | LCA filings | Avg salary |
|---|---|---|
| 2026 | 4 | $208,150 |
| 2025 | 2 | $222,500 |
| 2023 | 3 | $120,000 |
| 2022 | 5 | $127,529 |
Click a bar to filter records
Yearly filings & average salary · swipe to explore
SponsorStats AI
Summary